Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,180
datasets available to search
ShareScore release 0.9.0
Dataset results
2,180 results for “Recombination”
Recombinant Subunit Herpes Zoster Vaccine in VZV-Seronegative Organ Transplant Recipients
ClinicalTrials.gov study NCT03685682. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried
ClinicalTrials.gov study NCT03026972. IPD Sharing: NO. Countries: 1. Publications: 31.
Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis
ClinicalTrials.gov study NCT01486524. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to
ClinicalTrials.gov study NCT05142553. IPD Sharing: NO. Countries: 1. Publications: 3.
A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B
ClinicalTrials.gov study NCT01708564. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation
ClinicalTrials.gov study NCT04840992. IPD Sharing: NO. Countries: 1. Publications: 2.
Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)
ClinicalTrials.gov study NCT04961359. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed Africa
ClinicalTrials.gov study NCT02014727. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
ClinicalTrials.gov study NCT02015494. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers
ClinicalTrials.gov study NCT00001055. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
ClinicalTrials.gov study NCT03813940. IPD Sharing: Not stated. Countries: 1. Publications: 1.
hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF
ClinicalTrials.gov study NCT01365936. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18
ClinicalTrials.gov study NCT00500058. IPD Sharing: YES. Countries: 1. Publications: 1.
VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Hea
ClinicalTrials.gov study NCT02408913. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Ad
ClinicalTrials.gov study NCT04123366. IPD Sharing: YES. Countries: 23. Publications: 1.
Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine
ClinicalTrials.gov study NCT05373030. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
ClinicalTrials.gov study NCT05284812. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV
ClinicalTrials.gov study NCT05898464. IPD Sharing: NO. Countries: 1. Publications: 11.
Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
ClinicalTrials.gov study NCT01677572. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
ClinicalTrials.gov study NCT02417597. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.